Related Experiment Videos
Programming of brainstem serotonin transporter development by prenatal glucocorticoids
T A Slotkin1, G A Barnes, E C McCook
1Department of Pharmacology, Duke University Medical Center, Durham, NC 27710, USA.
Brain Research. Developmental Brain Research
|May 31, 1996
Summary
Prenatal exposure to glucocorticoids like dexamethasone can alter brain development. This study shows it increases serotonin transporter expression in the brainstem, impacting stress responses long-term.
Area of Science:
- Neuroscience
- Developmental Biology
- Pharmacology
Background:
- Prenatal stress and excess glucocorticoids are known to disrupt central nervous system development and stress reactivity.
- The specific impact on brainstem serotonergic neurons requires further investigation.
Purpose of the Study:
- To investigate the effects of prenatal dexamethasone exposure on the development of the serotonin presynaptic transporter in the brainstem.
- To determine if these effects are dose-dependent and persistent into adulthood.
Main Methods:
- Pregnant rats were administered varying doses of dexamethasone on specific gestational days.
- Serotonin transporter expression was assessed from birth to adulthood using [3H]paroxetine binding assays.
- Body and brainstem growth were measured to evaluate developmental effects.
Main Results:
- Dexamethasone exposure resulted in dose-dependent growth retardation.
- A significant, persistent elevation in serotonin transporter binding was observed, even at low doses.
- The highest dose showed reduced transporter effects due to impaired growth, with peak effects at intermediate doses.
- Effects were specific to transporter expression, not overall serotonin levels or nerve terminal density.
Conclusions:
- Prenatal dexamethasone exposure selectively and persistently programs the serotonin transporter in the brainstem.
- This programming is more sensitive to glucocorticoids than general development.
- Aberrant transporter expression may underlie altered synaptic function and physiological abnormalities following prenatal glucocorticoid exposure.